AKERO THERAPEUTICS INC

CUSIP: 00973Y108 Class: Common Stock

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 23,426 Value ($000) $1,250 Avg Close — Range —
Q4 2024
Shares 9,879 Value ($000) $275 Avg Close — Range —
Q3 2024
Shares 14,252 Value ($000) $409 Avg Close — Range —
Q2 2024
Shares 10,191 Value ($000) $239 Avg Close — Range —